Biogen Aktie
143,30
EUR
+2,50
EUR
+1,78
%
147,84
USD
-1,49
USD
-1,00
%
Biogen Aktie Analyse
| 14.09.12 | Biogen outperform | RBC Capital Markets | |
| 10.09.12 | Biogen neutral | UBS AG | |
| 07.09.12 | Biogen buy | Deutsche Bank Securities | |
| 28.08.12 | Biogen outperform | RBC Capital Markets | |
| 26.07.12 | Biogen outperform | RBC Capital Markets | |
| 26.07.12 | Biogen buy | Jefferies & Company Inc. | |
| 18.07.12 | Biogen neutral | Robert W. Baird & Co. Incorporated | |
| 11.07.12 | Biogen outperform | RBC Capital Markets | |
|
Werbung
|
|||
| 11.07.12 | Biogen buy | Stifel, Nicolaus & Co., Inc. | |
| 09.07.12 | Biogen buy | Stifel, Nicolaus & Co., Inc. | |
| 14.06.12 | Biogen buy | Jefferies & Company Inc. | |
| 14.06.12 | Biogen overweight | Barclays Capital | |
| 14.06.12 | Biogen outperform | RBC Capital Markets | |
| 14.06.12 | Biogen outperform | Oppenheimer & Co. Inc. | |
| 30.05.12 | Biogen outperform | RBC Capital Markets | |
| 30.05.12 | Biogen neutral | JP Morgan Chase & Co. | |
| 10.05.12 | Biogen buy | UBS AG | |
| 03.05.12 | Biogen overweight | Barclays Capital | |
| 03.05.12 | Biogen buy | Jefferies & Company Inc. | |
| 03.05.12 | Biogen outperform | RBC Capital Markets | |
| 03.05.12 | Biogen overweight | Morgan Stanley | |
| 27.04.12 | Biogen buy | Jefferies & Company Inc. | |
| 26.04.12 | Biogen outperform | Oppenheimer & Co. Inc. | |
| 17.04.12 | Biogen overweight | Barclays Capital | |
| 05.04.12 | Biogen buy | Goldman Sachs Group Inc. | |
| 03.04.12 | Biogen outperform | RBC Capital Markets | |
| 20.03.12 | Biogen outperform | RBC Capital Markets | |
| 16.03.12 | Biogen buy | Stifel, Nicolaus & Co., Inc. | |
| 13.03.12 | Biogen outperform | RBC Capital Markets | |
| 17.02.12 | Biogen outperform | RBC Capital Markets | |
| 02.02.12 | Biogen overweight | Barclays Capital | |
| 02.02.12 | Biogen outperform | RBC Capital Markets | |
| 25.01.12 | Biogen buy | Jefferies & Company Inc. | |
| 23.01.12 | Biogen outperform | RBC Capital Markets | |
| 13.01.12 | Biogen overweight | Barclays Capital | |
| 01.12.11 | Biogen overweight | Piper Jaffray & Co. | |
| 14.11.11 | Biogen outperform | RBC Capital Markets | |
| 01.11.11 | Biogen buy | UBS AG | |
| 31.10.11 | Biogen neutral | Citigroup Corp. | |
| 31.10.11 | Biogen buy | UBS AG | |
| 21.10.11 | Biogen outperform | RBC Capital Markets | |
| 19.10.11 | Biogen neutral | Citigroup Corp. | |
| 14.10.11 | Biogen outperform | RBC Capital Markets | |
| 14.10.11 | Biogen neutral | Citigroup Corp. | |
| 06.10.11 | Biogen outperform | RBC Capital Markets | |
| 29.09.11 | Biogen outperform | RBC Capital Markets | |
| 09.09.11 | Biogen buy | UBS AG | |
| 29.08.11 | Biogen outperform | RBC Capital Markets | |
| 18.08.11 | Biogen outperform | Oppenheimer & Co. Inc. | |
| 04.08.11 | Biogen outperform | RBC Capital Markets | |